Skip to main content
. 2004 Jul;78(13):6938–6945. doi: 10.1128/JVI.78.13.6938-6945.2004

FIG. 5.

FIG. 5.

Neutralization assay of pseudotype viruses. (A) The neutralizing activity of SARS patient serum and normal human serum (diluted 1:100) for HIV/SARS or HIV/VSV-G pseudovirus. (B) The neutralizing activity of the animal sera (1:10 to 1:320 diluted) for HIV/SARS pseudovirus. R31 and R32, antisera from the two rabbits immunized with Trx-F3; M31 to M34, antisera from the four mice immunized with Trx-F3; R91 and R92, antisera from the two rabbits immunized with Trx-F9; M91 to M94, antisera from the four mice immunized with Trx-F9; RC and MC, the preimmune sera from rabbits and mice. (C) The neutralizing activity of the two neutralizing antisera (M34 and R31) and their corresponding preimmune sera (MC and RC) (diluted 1:40) for HIV/VSV-G pseudovirus. All results of neutralization assays represent four repeated experiments.